N-Ethyl-N-(2-(ethylamino)ethyl)nitroxylamine
ADVERTISEMENT
- Molecular formula
- C6H16N3O2
- CAS Number
- 20721-10-8
- IUPAC Name
- N-[ethyl-[2-(ethylamino)ethyl]amino]-N-hydroxy-nitrous amide
- Molecular Weight
- 175.22g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.0101g/cm3
Identification
Interesting facts
Interesting Facts About N-[ethyl-[2-(ethylamino)ethyl]amino]-N-hydroxy-nitrous Amide
N-[ethyl-[2-(ethylamino)ethyl]amino]-N-hydroxy-nitrous amide is a fascinating compound that showcases the complex interplay between organic chemistry and medicinal applications. Here are some intriguing insights:
- Chemical Structure: This compound contains a combination of amine groups, hydroxyl functionalities, and a nitrous amide structure, which is significant as it allows for a variety of potential interactions with biological systems.
- Potential in Pharmacology: Due to its structural features, there is ongoing research into the compound's pharmacological applications, particularly how it might influence neurotransmitter systems and its potential as a therapeutic agent.
- Applications in Synthesis: N-hydroxy-nitrous amides are often utilized in organic synthesis, serving as precursors for various important chemical reactions, including the synthesis of nitrogen-containing compounds that are vital in this field.
- Biological Interest: Researchers are particularly interested in compounds like this one for their potential use in drug development, particularly in targeting certain pathways within biological systems.
- Chemical Stability: The presence of both amine and nitrous moieties in the structure suggests a balance between reactivity and stability, making it a subject of interest for studying stability under various conditions.
As we delve deeper into the study of N-[ethyl-[2-(ethylamino)ethyl]amino]-N-hydroxy-nitrous amide, it becomes clear that its unique molecular characteristics may play a crucial role in advancing both our understanding of chemical interactions and the development of new therapeutic agents.